Xenetic Biosciences (XBIO) Share-based Compensation (2014 - 2026)
Xenetic Biosciences (XBIO) posted Share-based Compensation of $51,964 for Q2 2026, up 231.3% from $15,683 a year earlier and up 359.4% from the prior quarter.
Powered by 
Analysis
Xenetic Biosciences (XBIO) Share-based Compensation (2014 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Share-based Compensation at Xenetic Biosciences was $93,129, up 6.3% year-over-year; for FY2025, it was $64,787, down 62.3% from FY2024.
- Annual Share-based Compensation has declined for three consecutive years, with a five-year compound annual growth rate of -32.7% (FY2020 to FY2025).
- In prior years, Xenetic Biosciences' Share-based Compensation was $171,814 in FY2024 (-39.3%), $283,085 in FY2023 (-44.7%), $511,480 in FY2022 (+24.6%) and $410,437 in FY2021 (-12.5%).
- The Q2 2026 figure stands as the highest quarterly Share-based Compensation since Q1 2024.
- On a year-over-year basis, Share-based Compensation increased in 1 of the last eight quarters, with an average decline of 20.2%.
- The strongest year-over-year quarter for Share-based Compensation in the past five years was Q2 2026, with growth of 231.3%; the weakest was Q1 2025, with a decline of 75.0%.
- According to Business Quant data, Share-based Compensation for the three prior quarters was $11,312 (Q1 2026), $13,998 (Q4 2025) and $15,855 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Xenetic Biosciences | 5.46 Mn | -20.36 Mn | - | 51,964.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 51,964.00 |
| Mar 31, 2026 | 11,312.00 |
| Dec 31, 2025 | 13,998.00 |
| Sep 30, 2025 | 15,855.00 |
| Jun 30, 2025 | 15,683.00 |
| Mar 31, 2025 | 19,251.00 |
| Dec 31, 2024 | 25,108.00 |
| Sep 30, 2024 | 27,536.00 |
| Jun 30, 2024 | 42,096.00 |
| Mar 31, 2024 | 77,074.00 |
| Dec 31, 2023 | 74,578.00 |
| Sep 30, 2023 | 70,266.00 |
| Jun 30, 2023 | 69,389.00 |
| Mar 31, 2023 | 68,852.00 |
| Dec 31, 2022 | 118,651.00 |
| Sep 30, 2022 | 137,364.00 |
| Jun 30, 2022 | 135,870.00 |
| Mar 31, 2022 | 119,595.00 |
| Dec 31, 2021 | 113,100.00 |
| Sep 30, 2021 | 111,131.00 |
API Access
Xenetic Biosciences Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=XBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "XBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=XBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();